Q3 Asset Management
- SEC CIK
- 0001732543
- Latest filing
- Aug 14, 2026
SMMT holding history
Summit Therapeutics Inc. in every 13F filed by Q3 Asset Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SMMT overviewAll 13F holders of SMMTFull Q2 2026 holdings
- Shares (Q2 2026)
- 19,950
- Value
- $290.0K
- % of portfolio
- 0.1%
- Quarters held
- 9
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 19,950 | $290.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 19,950 | $378.0K | 0.1% | +383+2.0% | Added | Holders |
| Q4 2025 | 19,567 | $342.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 19,567 | $404.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 19,567 | $416.0K | 0.1% | +3,094+18.8% | Added | Holders |
| Q1 2025 | 16,473 | $317.0K | 0.2% | 00.0% | Unchanged | Holders |
| Q4 2024 | 16,473 | $293.0K | 0.2% | 00.0% | Unchanged | Holders |
| Q3 2024 | 16,473 | $360.0K | 0.1% | +16,473 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −15,761−100.0% | Sold out | Holders |
| Q1 2023 | 15,761 | $27.0K | <0.1% | +15,761 | New | Holders |